The short version
BPC-157 and TB-500 are the most popular tissue-repair research peptides in existence, and their nickname — the Wolverine Stack, after the comic-book character who heals from injuries in minutes — reflects exactly what people hope they do. The animal data is genuinely compelling: tendons heal faster, gut injuries recover, joints recover, and inflammation drops in study after study. The significant limitation is that we do not yet have proper human clinical trials to confirm those effects in people. They are not approved, they are banned in tested sport, and they are sold as research chemicals. But the mechanism is coherent, the animal literature is substantial, and they are among the most studied unapproved peptides on the market.
What they are
BPC-157 ("Body Protection Compound") is a 15-amino-acid peptide originally found in human gastric juice. Your stomach lining contains it naturally, and it appears to play a role in protecting and repairing the gut. TB-500 is a synthetic version of a region of thymosin beta-4, a protein your body uses to repair tissue and support blood vessel formation. They are paired because their mechanisms complement each other — BPC-157 works primarily on growth-factor signalling and nitric oxide pathways, while TB-500 promotes cell migration into injured tissue and supports new blood vessel formation.
How they work — in plain English
BPC-157 appears to work by activating repair-related growth factors, increasing nitric oxide (which improves blood flow to injury sites), and modulating several signalling pathways involved in healing. TB-500 works differently — it influences actin, a protein essential to the structure of cells, and promotes the movement of cells into wounds and the formation of new blood vessels to supply them. Together, the theory is: BPC-157 sends the repair signals while TB-500 gets the cells and blood supply to where they are needed.
What the research actually shows
The animal literature is extensive and consistently positive. The human literature barely exists.
- Animal studies show BPC-157 accelerating healing of tendons, ligaments, muscles, bones and gut tissue across dozens of independent studies.
- Anti-inflammatory effects, protection of the gut lining, and even neurological protective effects have been observed in animal models.
- TB-500 animal data similarly shows improved wound healing, cardiac recovery after injury, and reduced inflammation.
- Human clinical trials are essentially absent for both compounds. Some early-phase safety work exists but no large efficacy trials.
Important considerations
Both peptides are on the World Anti-Doping Agency's prohibited list (class S0). Any athlete subject to drug testing risks disqualification. Product quality is also a genuine concern: research-grade materials have no regulatory oversight on purity, sterility or dose accuracy. There is also a theoretical safety question — because BPC-157 promotes blood vessel formation (angiogenesis), there is an unresolved question about whether that effect could support pre-existing undetected cancerous cells. Long-term human safety data does not yet exist to confirm or rule this out.